RecruitingOpioid Use DisorderChronic PainAnxiety Disorder
Low-Intensity Focused Ultrasound and the Complex Patient
Eligible age
18–65 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Studying the effects of Low Intensity Focused Ultrasound (LIFU) on measures of pain, craving, and anxiety in a complex patient population.
Sponsor: Virginia Polytechnic Institute and State University
You may qualify if…
- ✓ 1. Males and females aged 18-65 years
- ✓ 2. Current diagnosis of Chronic Back Pain as defined by pain duration of at least three months, with back pain being an ongoing problem for at least half the days of the last six months.
- ✓ 3. Have evidence of central sensitization (CS) as measured by the Widespread Pain/Symptom Severity Index (WPSSI) with a score of Widespread Pain Index (WPI) ≥ 7 and Symptom Severity (SS) ≥ 5 or WPI = 3-6 and SS ≥ 9.
- ✓ 4. Meet the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for current opiate use disorder as diagnosed by the Structured Clinical Interview for DSM-5.
- ✓ 5. Be in treatment for opioid use disorder (OUD) including buprenorphine or methadone.
- ✓ 6. Meet the DSM-5 criteria for a current anxiety disorder: generalized anxiety disorder, post-traumatic stress disorder or social anxiety disorder as diagnosed by the Structured Clinical Interview for DSM-5.
You may not qualify if…
- ✕ 1. Evidence of neuropathic pain
- ✕ 2. Previous spine surgery
- ✕ 3. Current substance use disorder other than OUD or tobacco use disorder
- ✕ 4. Current DSM-5 diagnosis of schizophrenia or schizo-affective disorder
- ✕ 5. Chronic Pain Conditions other than chronic back pain
- ✕ 6. Daily opiate use other than buprenorphine/methadone for OUD/pain control
- ✕ 7. Pregnant or breastfeeding
- ✕ 8. History of head injury, seizures, neurologic disorders including cerebrovascular disease, stroke, brain surgery, brain tumor, multiple sclerosis, or neurodegenerative diseases
Where it's recruiting
Virginia
Roanoke
Source: ClinicalTrials.gov · NCT06297200 · last updated 2025-11-03